High S100A2 expression has been associated with the regulation of tumor cell proliferation and invasion through the enhancement of PI3K/AKT activation and functional interaction with SMAD3 [35]; however, whether S100A2 expression has prognostic value in endometrial carcinoma has remained unknown. This evidence concerns the gene SMAD3 and neoplasm.